Stay Updated with the Latest EXMceuticals Inc. EXM.CN News in Real Time
Find EXM.CN news now at Meyka AI. Stay informed with the latest EXMceuticals Inc. stocks updates, including price news, market analysis, and expert insights.
Qualcomm Inc (NASDAQ: QCOM) Loses 1.86% to $221.90 as AI Expansion Gains Momentum but Stock Faces Pressure
Qualcomm Inc (NASDAQ: QCOM) pulled back 1.86% to $221.90 on June 23, 2026, even as its AI and automotive expansion story grows more concrete by the quarter. The stock trades within a 52-week range of $121.99 to $259.92, reflecting a sharp recovery from lows but still well off its all-time closing high of $250.10 from…
Tesla Inc Shares (NASDAQ: TSLA) up +1.14% After Jefferies Lowers Target to $375 Amid SpaceX Merger Talk
Tesla Inc. shares climbed 1.14% after analysts at Jefferies lowered their price target to $375, drawing fresh attention to the company’s future growth path. The move comes as investors closely watch rising speculation about a possible Tesla-SpaceX merger, a topic that has sparked intense debate across Wall Street in June 2026. While some see major…
Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029
Robinhood shares dropped roughly 4% on June 22, 2026, after the company announced a major capital raise before market open. Robinhood Markets, Inc. (NASDAQ: HOOD) intends to offer $2.0 billion in convertible senior notes due 2029 in a private placement to qualified institutional buyers under Rule 144A. Shares traded at $108.15 on June 22, within…
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…
CRH Eyes $8 Billion Arcosa Acquisition, Potential Deal Values Target at 13.7x EBITDA
CRH made its biggest-ever acquisition official on June 22, 2026, signing a definitive agreement to acquire Arcosa, Inc. (NYSE: ACA) in an all-cash transaction. CRH will pay $150 per share in cash, with the transaction valuing Arcosa at a total enterprise value of approximately $8.5 billion, representing an acquisition multiple of 11.5x 2026E Adjusted EBITDA,…
Tesla Inc (TSLA) +1.04%: Jefferies Revises Down Target, Highlights SpaceX Tracking Stock Risk
Tesla Inc (TSLA) traded higher by about 1% in recent sessions in June 2026, even as Wall Street turned cautious. In a fresh note, Jefferies revised its price target lower and flagged new concerns around valuation pressure. The report also pointed to growing risks linked to SpaceX-related tracking stock sentiment and Elon Musk’s wider business…
Tencent Holdings (HKG: 0700) at 434.00 HKD Up +1.41% as WeChat AI Assistant Testing Begins
Tencent Holdings stock gained 1.41% to 434.00 HKD on June 22, 2026, driven by a concrete and timely AI catalyst. Tencent Holdings Ltd. has started testing a new AI assistant for WeChat, known as Xiaowei, making it available to a small number of users, with users able to interact via text or voice to complete…
Affirm Stock Falls 5.3% to $70.73 on Valuation Concerns, June 18
Affirm stock fell 5.3% to $70.73 on June 17 amid valuation concerns and sector headwinds affecting the buy-now-pay-later fintech lender.
Strategy Inc (MSTR) Faces Dividend Strain as Bitcoin Holdings Weigh on Stock
MicroStrategy (MSTR) stock faces pressure as STRC preferred stock trades below par. Dividend coverage and acquisition strategy draw analyst scrutiny.